Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of Tuesday, October 6, 2026.
EARNINGS PER SHARE (EPS)
N/A
Market Cap
$3.54M
Earnings Per Share (EPS)
-14.40
TTM Avg
-19.95
3Y Avg
-16.43
5Y Avg
-17.45
Market Cap
$3.64M
Earnings Per Share (EPS)
-4.90
TTM Avg
-7.69
3Y Avg
-8.41
5Y Avg
-8.41
Market Cap
$3.60M
Earnings Per Share (EPS)
N/A
TTM Avg
-37.01
3Y Avg
-21.04
5Y Avg
-1.64
Market Cap
$3.49M
Earnings Per Share (EPS)
-0.45
TTM Avg
-1.48
3Y Avg
-5.05
5Y Avg
-8.12
Market Cap
$3.46M
Earnings Per Share (EPS)
N/A
TTM Avg
-130.80
3Y Avg
-71.47
5Y Avg
-57.18
Market Cap
$3.72M
Earnings Per Share (EPS)
-18.85
TTM Avg
-47.63
3Y Avg
-99.69
5Y Avg
-316.96
Market Cap
$3.79M
Earnings Per Share (EPS)
-0.91
TTM Avg
-1.99
3Y Avg
-3.92
5Y Avg
-2.83
Market Cap
$3.28M
Earnings Per Share (EPS)
N/A
TTM Avg
-1108.98
3Y Avg
-1045.55
5Y Avg
-1171.01
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eocene Ltd. (EOCN) | $3.54M | N/A | N/A | N/A | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.54M | -14.40 | -19.95 | -16.43 | -17.45 |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.64M | -4.90 | -7.69 | -8.41 | -8.41 |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.60M | N/A | -37.01 | -21.04 | -1.64 |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -0.45 | -1.48 | -5.05 | -8.12 |
| Moolec Science S.A. (MLEC)vs › | $3.46M | N/A | -130.80 | -71.47 | -57.18 |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.72M | -18.85 | -47.63 | -99.69 | -316.96 |
| Evogene Ltd. (EVGN)vs › | $3.79M | -0.91 | -1.99 | -3.92 | -2.83 |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.28M | N/A | -1108.98 | -1045.55 | -1171.01 |
| Aethlon Medical, Inc. (AEMD)vs › | $3.27M | -11.70 | -48.19 | -238.41 | -340.02 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
